|
Free Research Articles
Citations 371-380 of 789 total displayed.
|
Past content
(since May 2004):
|
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia
- Claire Dearden, Rachel Wade, Monica Else, Sue Richards, Don Milligan, Terry Hamblin, and Daniel Catovsky, for the UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group and NCRI CLL Working Group
Blood 2008; 111: 1820-1826.
[Abstract]
[Full text]
[PDF]
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
- Anthony H. Goldstone, Susan M. Richards, Hillard M. Lazarus, Martin S. Tallman, Georgina Buck, Adele K. Fielding, Alan K. Burnett, Raj Chopra, Peter H. Wiernik, Letizia Foroni, Elisabeth Paietta, Mark R. Litzow, David I. Marks, Jill Durrant, Andrew McMillan, Ian M. Franklin, Selina Luger, Niculae Ciobanu, and Jacob M. Rowe
Blood 2008; 111: 1827-1833.
[Abstract]
[Full text]
[PDF]
Historical review: megakaryopoiesis and thrombopoiesis
- Kenneth Kaushansky
Blood 2008; 111: 981-986.
[Abstract]
[Full text]
[PDF]
Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years
- Karen L. Syrjala, Brenda F. Kurland, Janet R. Abrams, Jean E. Sanders, and Julia R. Heiman
Blood 2008; 111: 989-996.
[Abstract]
[Full text]
[PDF]
Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void
- Lawrence R. Solomon
Blood 2008; 111: 997-1003.
[Abstract]
[Full text]
[PDF]
Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon- treatment
- Andreas Hochhaus, Brian Druker, Charles Sawyers, Francois Guilhot, Charles A. Schiffer, Jorge Cortes, Dietger W. Niederwieser, Carlo Gambacorti-Passerini, Richard M. Stone, John Goldman, Thomas Fischer, Stephen G. O'Brien, Jose J. Reiffers, Manisha Mone, Tillmann Krahnke, Moshe Talpaz, and Hagop M. Kantarjian
Blood 2008; 111: 1039-1043.
[Abstract]
[Full text]
[PDF]
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results
- Lionel Adès, Miguel A. Sanz, Sylvie Chevret, Pau Montesinos, Patrice Chevallier, Emmanuel Raffoux, Edo Vellenga, Agnès Guerci, Arnaud Pigneux, Francoise Huguet, Consuelo Rayon, Anne Marie Stoppa, Javier de la Serna, Jean-Yves Cahn, Sandrine Meyer-Monard, Thomas Pabst, Xavier Thomas, Stéphane de Botton, Ricardo Parody, Juan Bergua, Thierry Lamy, Anne Vekhoff, Silvia Negri, Norbert Ifrah, Hervé Dombret, Augustin Ferrant, Dominique Bron, Laurent Degos, and Pierre Fenaux
Blood 2008; 111: 1078-1084.
[Abstract]
[Full text]
[PDF]
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.
- Ruben Niesvizky, David S. Jayabalan, Paul J. Christos, Jessica R. Furst, Tara Naib, Scott Ely, Jessica Jalbrzikowski, Roger N. Pearse, Faiza Zafar, Karen Pekle, April LaRow, Richard Lent, Tomer Mark, Hearn J. Cho, Tsiporah Shore, Jeffrey Tepler, John Harpel, Michael W. Schuster, Susan Mathew, John P. Leonard, Madhu Mazumdar, Selina Chen-Kiang, and Morton Coleman
Blood 2008; 111: 1101-1109.
[Abstract]
[Full text]
[PDF]
Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort
- Charles T. Quinn, Nancy J. Lee, Elizabeth P. Shull, Naveed Ahmad, Zora R. Rogers, and George R. Buchanan
Blood 2008; 111: 544-548.
[Abstract]
[Full text]
[PDF]
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience
- Sophie Park, Sophie Grabar, Charikleia Kelaidi, Odile Beyne-Rauzy, Françoise Picard, Valérie Bardet, Valérie Coiteux, Geneviève Leroux, Pascale Lepelley, Marie-Thérèse Daniel, Stéphane Cheze, Béatrice Mahé, Augustin Ferrant, Christophe Ravoet, Martine Escoffre-Barbe, Lionel Adès, Norbert Vey, Lina Aljassem, Aspasia Stamatoullas, Lionel Mannone, Hervé Dombret, Keith Bourgeois, Peter Greenberg, Pierre Fenaux, and François Dreyfus, for the GFM group (Groupe Francophone des Myélodysplasies)
Blood 2008; 111: 574-582.
[Abstract]
[Full text]
[PDF]
|
|
